Episodes List

Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses
24 Mar, 2025
5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
21 Mar, 2025
Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel
20 Mar, 2025
Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig for Oncology Nurses
17 Mar, 2025
Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)
14 Mar, 2025
Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances
13 Mar, 2025
Localized Breast Cancer — Examining the Current Use of Genetic Testing and Related Clinical Management
11 Mar, 2025
Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)
06 Mar, 2025
5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
28 Feb, 2025
Biliary Tract Cancers — Reviewing Patient Cases with Prof John Bridgewater
27 Feb, 2025
Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies
21 Feb, 2025
Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
20 Feb, 2025
Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy
18 Feb, 2025
HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies
14 Feb, 2025
Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
12 Feb, 2025
5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
07 Feb, 2025
EGFR-Mutant Non-Small Cell Lung Cancer | Year in Review Series on Relevant New Datasets and Advances
05 Feb, 2025
Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani
03 Feb, 2025
5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
31 Jan, 2025
Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series
29 Jan, 2025
Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questions Posed by Patients
24 Jan, 2025
Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
22 Jan, 2025
Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
22 Jan, 2025
Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer
17 Jan, 2025
Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer
17 Jan, 2025
What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma
15 Jan, 2025
CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
15 Jan, 2025
Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
13 Jan, 2025
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Myelofibrosis
13 Jan, 2025